Fine Mark National Bank & Trust Becton Dickinson & CO Transaction History

Fine Mark National Bank & Trust

  • $2.68 Billion
  • Q1 2025

A detailed history of Fine Mark National Bank & Trust transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 1,376 shares of BDX stock, worth $237,483. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,376
Previous 1,609 14.48%
Holding current value
$237,483
Previous $365,000 13.7%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$222.79 - $249.08 $51,910 - $58,035
-233 Reduced 14.48%
1,376 $315,000
Q4 2024

Feb 11, 2025
SELL
$220.02 - $243.75 $15,841 - $17,550
-72 Reduced 4.28%
1,609 $365,000
Q3 2024

Nov 13, 2024
SELL
$221.47 - $242.41 $81,058 - $88,722
-366 Reduced 17.88%
1,681 $405,000
Q2 2024

Aug 02, 2024
SELL
$225.07 - $246.17 $15,304 - $16,739
-68 Reduced 3.22%
2,047 $478,000
Q1 2024

May 14, 2024
SELL
$233.45 - $247.73 $76,338 - $81,007
-327 Reduced 13.39%
2,115 $523,000
Q4 2023

Feb 09, 2024
SELL
$232.24 - $267.23 $57,595 - $66,273
-248 Reduced 9.22%
2,442 $595,000
Q3 2023

Nov 15, 2023
SELL
$254.9 - $283.59 $5.09 Million - $5.66 Million
-19,952 Reduced 88.12%
2,690 $695,000
Q2 2023

Aug 11, 2023
BUY
$238.39 - $265.32 $25,984 - $28,919
109 Added 0.48%
22,642 $5.98 Million
Q1 2023

May 08, 2023
BUY
$229.71 - $259.35 $255,896 - $288,915
1,114 Added 5.2%
22,533 $5.58 Million
Q4 2022

Feb 09, 2023
BUY
$218.29 - $256.91 $118,749 - $139,759
544 Added 2.61%
21,419 $5.45 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $36,639 - $189,717
718 Added 3.56%
20,875 $4.65 Million
Q2 2022

Aug 09, 2022
BUY
$234.74 - $275.42 $145,538 - $170,760
620 Added 3.17%
20,157 $4.97 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $260,451 - $289,143
1,069 Added 5.79%
19,537 $5.2 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $3.9 Million - $4.26 Million
16,957 Added 1122.24%
18,468 $4.64 Million
Q3 2021

Nov 12, 2021
SELL
$232.72 - $256.47 $26,995 - $29,750
-116 Reduced 7.13%
1,511 $371,000
Q2 2021

Aug 13, 2021
BUY
$232.65 - $254.58 $18,844 - $20,620
81 Added 5.24%
1,627 $396,000
Q1 2021

May 12, 2021
SELL
$232.09 - $256.88 $8,123 - $8,990
-35 Reduced 2.21%
1,546 $376,000
Q4 2020

Feb 10, 2021
SELL
$221.92 - $245.94 $27,740 - $30,742
-125 Reduced 7.33%
1,581 $396,000
Q3 2020

Nov 12, 2020
SELL
$215.77 - $276.76 $110,042 - $141,147
-510 Reduced 23.01%
1,706 $397,000
Q2 2020

Aug 13, 2020
SELL
$219.9 - $263.41 $1,319 - $1,580
-6 Reduced 0.27%
2,216 $530,000
Q1 2020

May 06, 2020
SELL
$195.69 - $279.01 $12,328 - $17,577
-63 Reduced 2.76%
2,222 $511,000
Q4 2019

Feb 07, 2020
BUY
$236.45 - $266.82 $62,659 - $70,707
265 Added 13.12%
2,285 $621,000
Q3 2019

Nov 08, 2019
BUY
$230.58 - $256.08 $83,008 - $92,188
360 Added 21.69%
2,020 $498,000
Q2 2019

Aug 08, 2019
BUY
$217.4 - $246.08 $92,612 - $104,830
426 Added 34.52%
1,660 $418,000
Q1 2019

May 07, 2019
SELL
$206.05 - $248.17 $526,251 - $633,826
-2,554 Reduced 67.42%
1,234 $308,000
Q4 2018

Feb 07, 2019
BUY
$204.73 - $257.93 $13,102 - $16,507
64 Added 1.72%
3,788 $854,000
Q3 2018

Nov 02, 2018
SELL
$233.07 - $256.0 $51,741 - $56,832
-222 Reduced 5.63%
3,724 $972,000
Q2 2018

Aug 03, 2018
SELL
$208.1 - $233.85 $1,248 - $1,403
-6 Reduced 0.15%
3,946 $945,000
Q1 2018

Apr 26, 2018
BUY
$205.46 - $240.27 $294,424 - $344,306
1,433 Added 56.89%
3,952 $856,000
Q3 2017

Oct 30, 2017
BUY
$186.89 - $198.9 $470,775 - $501,029
2,519
2,519 $494,000

Others Institutions Holding BDX

# of Institutions
1,806
Shares Held
257M
Call Options Held
3.24M
Put Options Held
841K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $49.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email